2013
DOI: 10.1136/postgradmedj-2012-131186
|View full text |Cite
|
Sign up to set email alerts
|

Superior vena cava stenting in the 21st century

Abstract: Superior vena cava obstruction (SVCO) is most commonly due to malignant or thrombotic causes. The traditional treatments of surgery, radiotherapy or chemotherapy either have a high morbidity and mortality rate, or a lag period of a few weeks prior to response. Superior vena cava stenting is able to provide rapid relief of symptoms safely in the vast majority of patients. It has now become the first-line treatment for malignant SVCO, and is increasingly being used in benign SVCO. The complication and success ra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0
4

Year Published

2014
2014
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 39 publications
0
8
0
4
Order By: Relevance
“…Fortunately, repeated endovascular treatment is possible. 6,7 There is no consensus with respect to effective anticoagulant therapy for prevention of stent thrombosis after SVC recanalization. Oral anticoagulants or antiplatelet agents are typically used for several months.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Fortunately, repeated endovascular treatment is possible. 6,7 There is no consensus with respect to effective anticoagulant therapy for prevention of stent thrombosis after SVC recanalization. Oral anticoagulants or antiplatelet agents are typically used for several months.…”
Section: Discussionmentioning
confidence: 99%
“…No comparative studies are yet available to analyze both strategies in this group of patients. [6][7][8][9] The antithrombotic regimen used in our patient during a 30-day follow-up (ie, low-molecular-weight heparin and dual antiplatelet therapy) resulted from our experience in endovascular treatment of arterial disease and thrombosis prevention. Aggressive management was associated with the extent of recanalization and stent length exceeding 120 mm.…”
Section: Discussionmentioning
confidence: 99%
“…Stenting should be considered in these circumstances. Stent placement is now the first‐line treatment for malignant SVC obstruction to establish long‐term venous patency, and it is increasingly being used in benign SVC obstruction . Stent placement across existing leads in patients with pacemaker‐related SVC syndrome has been described in small case series .…”
Section: Discussionmentioning
confidence: 99%
“…Balloon angioplasty and stent implantation are valid and reliable methods to treat stenoses of the SVC successfully [6]. It has become the first-line treatment of obstructions of the SCV and the success and complication rates are very promising [7]. …”
Section: Discussionmentioning
confidence: 99%